Fri, March 31, 2023

Jason McCarthy Maintained (BCLI) at Strong Buy with Increased Target to $150 on, Mar 31st, 2023

  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. th-increased-target-to-150-on-mar-31st-2023.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
  • 🞛 This publication is a summary or evaluation of another publication
  • 🞛 This publication contains potentially derogatory content such as foul language or violent themes
Jason McCarthy of Maxim Group, Maintained "Brainstorm Cell Therapeutics Inc." (BCLI) at Strong Buy with Increased Target from $75 to $150 on, Mar 31st, 2023.

Jason, nor any peers, have made any analyst calls on BCLI in the last 4 months.

Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30